How many investments has 1315 Capital made?

1315 Capital has 37 tracked investments, 1 of which have exited via acquisition or IPO, including 2 dated in the last 24 months.

What stage does 1315 Capital invest at?

1315 Capital invests at the Growth stage.

What is 1315 Capital's typical check size?

1315 Capital typically writes checks of $5M – $40M.

Where is 1315 Capital located?

1315 Capital is headquartered in Philadelphia, US.

Who does 1315 Capital co-invest with?

1315 Capital most often shares deals with SV Health Investors, Aisling Capital, Canaan Partners, among 12 tracked co-investors.

1315 Capital

Growth equity

Philadelphia · Growth · 20 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

1315 Capital specializes in healthcare investing, focusing on four healthcare verticals where its deep domain expertise enables it to add tangible value. The firm supports exceptional teams and companies through operational improvements, strategic initiatives, and growth acceleration, positioning itself under a 'Healthcare for Life' approach.

Invests inBiotech Digital Health Healthtech Medical Devices Wellness & Fitness Philadelphia United States

Source: firm website, verified Aug 25, 2026.

Stage

Growth

Check

$5M – $40M

Philadelphia, Pennsylvania, US

Instruments

Equity

Founded

2014

Last 12 months

1 investment

AUM

$1.4B

Tracked investments

Team · 20 people

from the firm's website & public directories

Adele C. Oliva· Founding Partner· Philadelphiain

Adele C. Oliva is a healthcare investor with more than 20 years of experience who founded 1315 Capital in 2014 to focus on healthcare growth equity and buyouts. She previously joined Quaker Partners in 2007 to build out their growth-stage investing practice and earlier served as Co-Head of US Healthcare at Apax Partners across Silicon Valley and Manhattan. She began her career at CoreStates and Baxter Healthcare, entered private equity as a Kauffman Fellow, and holds a BSc from St. Joseph's University and an MBA from Cornell University.

a•••@1315capital.comreveal

Michael Koby· Founding Partner· Philadelphia, Pennsylvania, United Statesin

Michael Koby co-founded 1315 Capital in 2014 and has spent his career as a healthcare investor and operator, previously serving as Managing Director leading healthcare investing at Palm Ventures and as an investor at Galen Partners. He holds a BSc from Cornell University and an MBA in Healthcare Management from The Wharton School.

m•••@1315capital.comreveal

Matthew Reber· Partner

Matthew Reber joined 1315 Capital as a Partner in 2017, having previously spent nine years at HealthCare Royalty Partners, where he was a Managing Director, along with earlier roles at Accretive LLC, Paul Capital Partners, Oak Hill Capital Partners, J.H. Whitney & Co., and Morgan Stanley. His investing work focuses on the pharma/medtech outsourcing and pharma/medtech product sectors. He holds a BSc in Engineering from Princeton University, an MBA from The Wharton School, and a Master of Biotechnology from the University of Pennsylvania.

m•••@1315capital.comreveal

Craig Matturro· Principal· Philadelphia, Pennsylvania, United Statesin

Craig Matturro joined 1315 Capital in 2016, having previously spent two years as an analyst in the investment banking group at Leerink Partners, where he worked on M&A and private placement engagements for healthcare companies. While at 1315 Capital he served on secondment as Director of Business Development for portfolio company JDS Therapeutics, leading the divestiture of its Nutrition21 division and the acquisition of nutraceutical assets by its Bonafide Health division. He holds a BSc in Business Administration with a concentration in Finance and a minor in Engineering Studies from Carnegie Mellon University.

c•••@1315capital.comreveal

Ian B. Li· Principal· Philadelphia, Pennsylvania, United Statesin

Ian Li joined 1315 Capital in 2015 and is a Principal on the investment team. Before moving into investing, he worked as a healthcare management and strategy consultant at Capgemini Consulting and in quality engineering at Stryker Orthopaedics. He holds a BSE in Biomedical Engineering with an Economics minor from Duke University.

i•••@1315capital.comreveal

Jordan Brown· Principal· Philadelphia, Pennsylvania, United Statesin

Jordan Brown joined 1315 Capital in 2020. She previously served on the investment team at Northwell Ventures, focusing on early-stage healthcare IT, medical technology, and healthcare services companies across sourcing, due diligence, and portfolio support. Earlier, she worked in biopharmaceutical business development and started her career in Piper Jaffray's Healthcare Investment Banking group. She holds a BA (magna cum laude) and an MBA from the University of Pennsylvania and the Wharton School.

j•••@1315capital.comreveal

Jacqueline Akpan· Controller· United Kingdomin

Jake Baker· Business Development Associate· Philadelphia, Pennsylvania, United Statesin

Joe Schlitz· Associate· Philadelphia, Pennsylvania, United Statesin

Marisa Powell· Associate· Greater Philadelphiain

Michael Satow· Operating Team Member

Member of 1315 Capital's Operating Team; not an employee of the firm.

Nate Painter· Senior Accountant

Rob Schrepfer· Operating Team Member

Member of 1315 Capital's Operating Team; not an employee of the firm.

Scott Cramer· Operating Team Member

Member of 1315 Capital's Operating Team; not an employee of the firm.

Tom Burnell· Operating Team Member

Member of 1315 Capital's Operating Team; not an employee of the firm.

Brian Schwenk· Chief Financial Officer & Chief Compliance Officer· Phoenixville, Pennsylvania, United Statesin

Brian Schwenk joined 1315 Capital in 2014 and has 14 years of experience in private equity and public accounting. Before that, he worked with Adele Oliva at Quaker Partners as CFO from 2012, and spent nearly seven years at Quaker affiliate Independence Capital Partners, most recently as Senior Controller. Earlier roles included audit positions at American Express Tax & Business Services, Stout Causey Consulting, and Arthur F. Bell, Jr. & Associates.

b•••@1315capital.comreveal

Jamie Richardson· Director of Business Development· United Statesin

Jamie Richardson joined 1315 Capital in 2020 after more than three years at ProMedica, where he served most recently as an Investment Associate working on debt and equity financings of healthcare companies and handling due diligence, investment committee approval, and transaction processes for the ProMedica Ventures portfolio. He also supported portfolio companies on business and financial strategy. He holds a BA and an MBA in Finance from the University of Toledo, where he was an NCAA Division I golfer.

j•••@1315capital.comreveal

Katherine Medlock· Associate

k•••@1315capital.comreveal

Russ Rapaport· Associate· New York, New York, United Statesin

Russ Rapaport joined 1315 Capital in 2024. He previously worked as a Senior Analyst at Health Advances, a healthcare strategy consulting firm, where he handled due diligence and growth strategy projects in MedTech, Digital Health, and health information technology. Earlier, he interned at medical device startup Vayu Global Health Innovations and at MedTech venture firm Bioventures Investors, and he holds a BA in Economics and Engineering Sciences from Dartmouth College.

r•••@1315capital.comreveal

Ryan Kraus· Vice President· Philadelphia, Pennsylvania, United Statesin

Ryan Kraus joined 1315 Capital in 2020. He previously worked as an Analyst at MTS Health Partners on M&A and financing transactions in the pharmaceutical, biotechnology, and healthcare services sectors, and before that held a Corporate Strategy and Business Development role at Pacira BioSciences. He holds a BS in Finance from Rutgers University.

r•••@1315capital.comreveal

What they invest in

from 23 of 43 portfolio companies

Healthtech ×17Biotech ×10Medical Devices ×10Deep Tech ×4Wellness & Fitness ×4Advanced Manufacturing ×3Consumer ×2Digital Health ×2

HQs:United States×21

Investments · 43 tracked

founders shown can be your intro path

By year:2025 · 1 2024 · 2 2022 · 1 2021 · 1 2019 · 1 2017 · 5 2015 · 1 2014 · 113 dated

TELA Bio in 𝕏NASDAQ: TELAJan 2017SEC filingmedium confidence

BiotechMalvern, US

Antony Koblish(Executive Officer, Director)Francis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)

BoardKevin Rakin(Director)Ashley Freidman(Director)

Board seatAdele C. Oliva· per SEC Form D · $7.5M raise · filed Jan 2017

Co-investorsCheckmate Capital Group LLC Essex Woodlands Healthcare Partners OrbiMed Signet Healthcare Partners

Interpace BiosciencesOTC: IDXG

HealthtechParsippany, US

Christopher McCarthy(Chief Financial Officer)Thomas W. Burnell(Executive Officer, Director)James Early(CFO)Jack E Stover(President and CEO)

BoardStephen J. Sullivan(Director)Vijay Aggarwal(Director)

Neuroneticsneurostar.com inNASDAQ: STIM

HealthtechMalvern, US

Mark R. Bausinger(Executive Officer)Christopher Thatcher(Executive Officer, Director)

BoardStephen Campe(Director)Robert Kuhling(Director)Liam Ratcliffe(Director)P. Sherrill Neff(Director)

Co-investorsAscension Ventures Atlas Venture

Spineology Incspineology.com inNov 2025✓ verified

Spineology develops minimally invasive spine surgery implants, including its flagship OptiMesh interbody fusion technology that delivers a bone graft-containing implant through a small surgical portal.

BiotechHardwareHealthtechMedical DevicesSt. Paul, US

Stephen D. Kuslich(Founder)JAMISON YOUNG(Executive Officer)BRIAN SNIDER(Executive Officer, Director)Brian Snider(Chief Executive Officer & Board Member)Steve Nemitz(Chief Financial Officer)Amanda Bloom(Executive Vice President, Marketing)

Board seatCraig Matturro· per SEC Form D

Co-investorsSV Health Investors RC Capital

CortiCarecorticare.com in 𝕏✓ verified

CortiCare provides remote EEG monitoring and interpretation services for hospitals and healthcare organizations to help address staffing shortages and expand access to neurophysiologist expertise.

Digital HealthHealthtechMedical Devices

Co-investorsHCAP Partners

Coloresciencecolorescience.comJul 2017

Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types.

ConsumerDirect to ConsumerHealthtechWellness & FitnessCarlsbad, US

Stephen Loomis(Executive Officer)Mary Fisher(Executive Officer, Director)Theodore Ebel(Executive Officer)Mary M. Fisher(Executive Officer, Director)Theodore O. Ebel(Executive Officer)Josie Juncal-Schwarz(Executive Officer)

Board seatAdele C. Oliva· per SEC Form D

Co-investorsAisling Capital Domain Associates HealthCare Ventures, LLC Longwood Fund RoundTable Healthcare Partners Split Rock Partners

Encore DermatologyApr 2019

HealthtechMalvern, US

Robert Moccia(Executive Officer, Director)

Board seatAdele C. Oliva· per SEC Form D

Co-investorsEssex Woodlands Healthcare Partners

Greenbrook TMSMar 2021SEC filingmedium confidence

HealthtechToronto

William Leonard(Executive Officer, Director)Diana Shi(Executive Officer)Frank Tworecke(Director)Euphia Hsu Smith(Executive Officer)Erns Loubser(Executive Officer)Brian P. Burke(Director)

Board seatAdele C. Oliva· per SEC Form D · $15.7M raise · filed Jul 2022

NovaSomnovasom.comMay 2014SEC filingmedium confidence

HealthtechGlen Burnie, US

Mark Janofsky(Executive Officer)Greg Stokes(Executive Officer)John Spitznagel(Executive Officer, Director)Michael Coppola(Executive Officer)

BoardEran Nadav(Director)Steve Grenfell(Director)

Board seatAdele C. Oliva· per SEC Form D · $7.5M raise · filed Jun 2019

Co-investorsEmergent Medical Partners, LLP

Onkos Surgicalonkossurgical.com in 𝕏Apr 2017

Onkos Surgical develops limb salvage and orthopedic reconstruction implants and systems for treating musculoskeletal cancer and complex orthopedic conditions.

HardwareHealthtechMedical DevicesParsippany, US

Patrick Treacy(Founder)inAntony Koblish(Director, Promoter)Brad Tyler(Executive Officer)

BoardAdele Oliva(Director)Stephen Bloch(Director)Paul Touhey(Director)

Board seatAdele C. Oliva· per SEC Form D

Co-investorsCanaan Partners JSD Capital, LLC SV Health Investors

Soluble SystemsOct 2017SEC filingmedium confidence

HealthtechNewport News, US

Allan R. Staley(Executive Officer, Director)T. Kerry McCarter(Executive Officer, Director)Guy G. Levy(Executive Officer, Director)Thomas Zeni(Executive Officer)Linwood Staub(Executive Officer, Director)

BoardWilliam R. Easby-Smith(Director)

Board seatMichael Koby· per SEC Form D · $28.3M raise · filed Nov 2017

Sprout2Dec 2017SEC filingmedium confidence

BiotechRaleigh, US

Margaret Henry(Executive Officer)Cynthia Eckert(Executive Officer, Director)Eric Atkins(Executive Officer)Cynthia Whitehead(Executive Officer, Director)

BoardAdele Oliva(Director)inSandra McGlothlin(Director)

Board seatAdele C. Oliva· per SEC Form D · $6.6M raise · filed Jan 2018

3B Scientific

Aktana

Aluris Sciences

Biocoat

Centurion Service Groupcenturionservice.com in 𝕏acquired by Trimedx

Centurion Service Group runs live and timed auctions for surplus and used medical equipment, connecting hospitals, surgery centers, and equipment dealers as sellers with domestic and international buyers.

HealthtechMarketplacesMedical DevicesChicago, US

Chc Solutions

Coating Place

Codis

Corticare

Expericexpericservices.com inOct 2024

Experic is a CDMO (Contract Development and Manufacturing Organization) specializing in inhalation pharmaceutical product development, formulation engineering, and clinical manufacturing services.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesCranbury, US

David Wood(Executive Officer, Director)

BoardDerek Hennecke(Director)inMatthew Reber(Director)Thomas Weller(Director)William Mitchell(Director)Andrew Frazier(Director)

Genoptix

Homestead Smart Health Plans

Innovative Health

Integration Health

Jds Therapeutics

Medivant Healthcaremedivanthealth.com

Medivant Healthcare manufactures sterile injectable medications for the pharmaceutical industry.

Advanced ManufacturingBiotechHealthtechMedical Devices

Miradrymiradry.com in

miraDry provides a non-invasive medical treatment aimed at improving patients' physical and emotional wellbeing, marketed to clinical customers and patients.

HealthtechMedical DevicesWellness & Fitness

Co-investorsAisling Capital Cross Creek Advisors

Misonix

Co-investorsSofinnova Ventures SV Health Investors

Mosaic Diagnostics

Nu Tekbiosciencesnu-tekbiosciences.com in

Nu-Tek BioSciences manufactures plant- and yeast-based cell culture nutrients and fermentation supplements for pharmaceutical and biotechnology companies.

Advanced ManufacturingBiotechImpact & Social GoodNew Materials

Thomas Yezzi(Founder & CEO)

Co-investorsAgent Capital

Nutrisensenutrisense.io in 𝕏Jun 2022

Nutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis.

Digital HealthHealthtechWellness & FitnessChicago, US

Kara Collier(Cofounder)inAleksey Skryl(Executive Officer, Director)Bogdan Zavorotny(Director, Executive Officer)Jessica Hou(Director)

BoardMichael Satow(Director)

Co-investorsAllied Venture Partners Hyperguap Techstars

Primrose Bioprimrosebio.com in 𝕏Jun 2024

Primrose Bio develops high-efficiency production systems for innovative and complex biologics, using advanced protein expression and enzyme engineering technologies deployed across commercially proven platforms.

BiotechDeep TechMedical DevicesSan Diego, US

Helge Zieler(Director, Executive Officer)Drew Burch(Chief Executive Officer)Diane Retallack, PhD(President & Chief Operating Officer)

BoardJ. Todd Mitchell(Director)Matthew Korenberg(Director)Matthew Reber(Director)

Co-investorsAgent Capital

Proscientoprosciento.com in

Reaction Biologyreactionbiology.com in 𝕏

Reaction Biology provides drug discovery and development services for pharmaceutical companies, offering preclinical research platforms including biochemistry, in vivo efficacy testing, and patient-derived xenograft models.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesMalvern, US

Haiching Ma(Chief Scientific Officer)

Restorative Therapies

Scisafescisafe.com in

SciSafe provides biopharmaceutical storage, sample management, and cold chain logistics services for pharmaceutical companies, research institutes, and biotech firms across regulated temperature-controlled facilities.

BiotechHealthtechLogistics & Supply ChainEast Brunswick, US

Seraphina Therapeuticsseraphinatherapeutics.com in 𝕏

Seraphina Therapeutics develops food- and nature-based consumer health products, starting with the fatty acid C15:0 (pentadecanoic acid), aimed at replenishing micronutrients and metabolites that decline with age.

ConsumerLongevityWellness & Fitness

Co-investorsBioBrit

Surmodics Fka Biocoat

Triple Ring Technologiestripleringtech.com inNov 2015

Newark, US

Joseph Anthony Heanue(Executive Officer, Director)Brian Patrick Wilfley(a Director prior to November 23, 2015)Lester John Lloyd(a Director prior to November 23, 2015)Augustus Percival Lowell(a Director prior to November 23, 2015)Philip Henry Devlin(Executive Officer)Muslim Tyebjee(Executive Officer)

Uspharma

Verogenverogen.com in 𝕏

Verogen provides NGS sequencing systems and reagent solutions for forensic and research laboratories, with offerings including the MiSeq FGx Sequencing System and flexible financing options like leasing, reagent rental programs, and bundled workflows.

BiotechData & InfrastructureDeep TechGovTechLegalTechMedical DevicesSan Diego, US

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 4

IPOs and acquisitions across the tracked portfolio

TELA BioNASDAQ: TELAInterpace BiosciencesOTC: IDXGNeuroneticsNASDAQ: STIMCenturion Service Groupacq. by Trimedx

Portfolio news

latest coverage across their companies

Earnings call transcript: TELA Bio misses Q2 2026 estimates, withdraws guidance By Investing.com

TELA Bio · investing.com · Aug 10, 2026

Interpace Biosciences | Morris Plains other | Altss

Interpace Biosciences · altss.com · Jun 3, 2026

RoundTable Colorescience Investment Drives Skincare Growth - Los Angeles Times

Colorescience · latimes.com · Feb 25, 2026

Spineology Launches OptiMesh® HA Nano

Spineology Inc · businesswire.com · Jan 13, 2026

Primrose Bio | 1315 Capital

Primrose Bio · 1315capital.com · Sep 23, 2025

Experic | 1315 Capital

Experic · 1315capital.com · Sep 23, 2025

Fund performance · per public LP disclosures · 3

as of Jun 2025

Fund	Vintage	Committed	Net IRR	TVPI	DPI
1315 Capital Fund IIILPs: Los Angeles City Employees' Retirement System	2022	—	-7.1%	0.94x	0.00x
1315 Capital Fund IILPs: Los Angeles City Employees' Retirement System	2018	—	12.6%	1.40x	0.51x
1315 Capital FundLPs: Los Angeles City Employees' Retirement System	2015	—	17.0%	2.14x	1.18x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

How many investments has 1315 Capital made?: 1315 Capital has 37 tracked investments, 1 of which have exited via acquisition or IPO, including 2 dated in the last 24 months.
What stage does 1315 Capital invest at?: 1315 Capital invests at the Growth stage.
What is 1315 Capital's typical check size?: 1315 Capital typically writes checks of $5M – $40M.
What sectors does 1315 Capital focus on?: 1315 Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices, Wellness & Fitness.
Where is 1315 Capital located?: 1315 Capital is headquartered in Philadelphia, US.
Who does 1315 Capital co-invest with?: 1315 Capital most often shares deals with SV Health Investors, Aisling Capital, Canaan Partners, among 12 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Scaling Healthcare for Life: A Conversation with Adele C. Oliva of 1315 Capital

dakota Live! Podcast · Adele C. Oliva

Images

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.

$100K – $20M

Marram Ventures

Marram Ventures is a healthcare-focused venture firm investing in companies connecting whole-person health to long-term outcomes, spanning integrated care delivery, diagnostics, and healthcare data interoperability.

$3M

Gore Range Capital

Gore Range Capital is a specialized healthcare investment firm building science-led platforms across precision health, regenerative medicine, personalized therapeutics, and longevity. It provides strategic, financial, and clinical guidance to portfolio companies developing next-generation healthcare solutions.

$500K – $5M

SPRINGROCK VENTURES

SpringRock Ventures is a Seattle-based venture firm investing in the convergence of healthcare and information technology, backing companies across digital health, medical devices, oral health, healthcare SaaS and related innovation.

$2M – $5M